Guardant Health (GH) Deferred Taxes (2019)

Guardant Health (GH) posted Deferred Taxes of -$2.8 million for Q4 2019.

Guardant Health (GH) Deferred Taxes (2019) Analysis & Trends

Guardant Health has reported Deferred Taxes for 1 years, with the latest figure at -$2.8 million in Q4 2019.

  • Quarterly Deferred Taxes changed N/A year-over-year to -$2.8 million in Q4 2019, while the trailing twelve-month figure through Dec 2020 was -$2.8 million (changed 0.0% YoY) and the FY2022 annual result came in at $99.8 million, changed N/A from the prior year.
  • Deferred Taxes was little changed at -$2.8 million in Q4 2019 per GH's latest filing.
  • Over five years, Deferred Taxes peaked at -$2.8 million in Q4 2019 and troughed at -$2.8 million in Q4 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Thermo Fisher Scientific 213.40 Bn 209.33 Bn 8.34 Bn -208.00 Mn
2 Danaher 139.94 Bn 135.59 Bn 3.61 Bn -
3 Idexx Laboratories 46.03 Bn 45.83 Bn 779.09 Mn 6.54 Mn
4 Agilent Technologies 39.69 Bn 37.88 Bn 990.00 Mn 32.00 Mn
5 Iqvia Holdings 39.32 Bn 37.24 Bn 1.44 Bn -36.00 Mn
6 Natera 38.47 Bn 37.37 Bn 696.04 Mn -
7 Illumina 29.98 Bn 28.82 Bn 770.00 Mn -21.00 Mn
8 Mettler Toledo International 28.57 Bn 28.52 Bn 650.22 Mn 1.82 Mn
9 Quest Diagnostics 26.21 Bn 25.58 Bn 1.03 Bn -2.00 Mn
10 Guardant Health 21.55 Bn 20.49 Bn 219.03 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2019 -2.83 Mn